Latest News and Press Releases
Want to stay updated on the latest news?
-
Successful completion of first-in-man study with EVT 103 Positive feedback from the FDA to initiate Phase II with EVT 101 HAMBURG, Germany, March 10, 2010 (GLOBE NEWSWIRE) -- Evotec AG...
-
HAMBURG, Germany, March 1, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) is going to broadcast its press & analyst conference in Frankfurt live on the internet. The Management Board...
-
HAMBURG, Germany, Feb. 25, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has extended its research agreement with Cubist Pharmaceuticals, Inc. (Nasdaq:CBST) to...
-
Development of preclinical candidate in the field of anaemia Evotec to provide integrated biology, chemistry and preclinical development activities Project worth in excess of EUR 5.5...
-
* Strategic alliance with CHDI aimed at accelerating efforts to develop drugs against Huntington's disease * Entails research revenue of up to US$ 37.5 million over the next three years ...
-
HAMBURG, Germany and ABINGDON, UK, Dec. 14, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has received a milestone payment from Ono Pharmaceutical Co., Ltd. (Ono)...
-
HAMBURG, Germany, Nov. 18, 2009 (GLOBE NEWSWIRE) -- Evotec (Frankfurt:EVT) (TecDAX), a leading provider in the discovery and development of novel small molecule drugs, today announced that it has been...
-
HAMBURG, Germany, Nov. 12, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (Nasdaq:EVTC) today reported results and corporate updates for the third quarter and nine months ended September...
-
HAMBURG, Germany, Nov. 10, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX), a leading provider in the discovery and development of novel small molecule drugs today announced that it plans...
-
HAMBURG, Germany, Nov. 9, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (Nasdaq:EVTC) today announced that it has extended the research collaboration with Boehringer Ingelheim for a...